US2020157159A1PendingUtilityA1

Peptide compounds and compositions thereof

Assignee: UNIV OKLAHOMAPriority: Apr 16, 2013Filed: Jan 29, 2020Published: May 21, 2020
Est. expiryApr 16, 2033(~6.7 yrs left)· nominal 20-yr term from priority
A61K 45/06A61K 38/00A61K 38/1729C07K 14/4723A61K 38/17A61K 9/06A61K 9/0048Y02A50/30A61K 31/496A61K 38/12A61K 9/0014A61K 31/546A61K 31/5383
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Peptide compounds and compositions containing the peptide compounds and methods for treating various infections, wounds, and skin conditions such as atopic dermatitis. Examples of wounds that may be treated include surface wounds such as lacerations, abrasions, avulsions, incisions, and amputations, pressure sores, bed sores, wounds due to peripheral vascular disease, post-surgical wounds, diabetic ulcers and wounds, burns, ocular wounds and abrasions, ocular ulcers, and treatment of inflammatory conditions such as dry eye. The peptide compounds and compositions may be used as treatments to enhance acceptance of grafts such as skin grafts and organ grafts.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A topical composition, comprising:
 a peptide compound comprising a sequence selected from the group consisting of:   
       
         
           
                 
               
                   (SEQ ID NO: 48) 
                 
                   (AEEA)-(AEEA)-RRRRLDREANLTSSVTILPLPLQNATVEAGTRR, 
                 
                   and 
                 
                     
                 
                   (SEQ ID NO: 50) 
                 
                   (AEEA)-(AEEA)-RRRRTSSVTILPLPLQNATVEAGTRR, 
                 
             
                
                
                
                
                
                
               
            
           
         
         
           wherein AEEA is NH 2 CH 2 CH 2 OCH 2 CH 2 OCH 2 CO—; and 
         
         a pharmaceutically-acceptable vehicle, carrier, or diluent which promotes transdermal absorption of the peptide compound. 
       
     
     
         2 . The topical composition of  claim 1 , comprising a lotion, paste, gel, cream, ointment, powder, spray, or aerosol. 
     
     
         3 . A topical composition, comprising:
 a peptide compound comprising a sequence selected from the group consisting of:   
       
         
           
                 
               
                   (SEQ ID NO: 46) 
                 
                   (AEEP)-(AEEP)-RRRRLDREANLTSSVTILPLPLQNATVEAGTRR, 
                 
                   and 
                 
                     
                 
                   (SEQ ID NO: 49) 
                 
                   (AEEP)-(AEEP)-RRRRTSSVTILPLPLQNATVEAGTRR, 
                 
             
                
                
                
                
                
                
               
            
           
         
         
           wherein AEEP is NH 2 CH 2 CH 2 OCH 2 CH 2 OCH 2 CH 2 CO—; and 
         
         a pharmaceutically-acceptable vehicle, carrier, or diluent which promotes transdermal absorption of the peptide compound. 
       
     
     
         4 . The topical composition of  claim 3 , comprising a lotion, paste, gel, cream, ointment, powder, spray, or aerosol. 
     
     
         5 . A topical composition, comprising:
 a peptide compound comprising a sequence selected from the group consisting of:   
       
         
           
                 
               
                   (SEQ ID NO: 51) 
                 
                   (AEEA)-(AEEA)-RRRRGTRCQVAGWGSWHSGGRLSRFPRFVNVR, 
                 
                   and 
                 
                     
                 
                   (SEQ ID NO: 35) 
                 
                   (AEEP)-(AEEP)-RRRRGTRCQVAGWGSWHSGGRLSRFPRFVNVR, 
                 
             
                
                
                
                
                
                
               
            
           
         
         
           wherein AEEA is NHCH 2 CH 2 OCH 2 CH 2 OCH 2 CO—, and AEEP is NH 2 CH 2 CH 2 OCH 2 CH 2 OCH 2 CH 2 CO—; and 
         
         a pharmaceutically-acceptable vehicle, carrier, or diluent which promotes transdermal absorption of the peptide compound. 
       
     
     
         6 . The topical composition of  claim 5 , comprising a lotion, paste, gel, cream, ointment, powder, spray, or aerosol.

Join the waitlist — get patent alerts

Track US2020157159A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.